Pulmicort flexhaler kupongkort
Flexhaler is safe and effective in children younger than 6 years of age. It is possible that cough, wheezing, or bronchospasm may occur in patients who have a severe milk protein allergy see Contraindications (4), Adverse Reactions (6.2). Once you have opened an envelope, you must use the ampules within 2 weeks. Continue to hold your Pulmicort Flexhaler upright as shown in Figure. Your Pulmicort Flexhaler has a dose indicator window just below the mouthpiece. Treatment with pulmicort flexhaler should be discontinued and alternate therapy instituted. What should I tell my healthcare provider before using Pulmicort Flexhaler? These same data were utilized in a second study bringing the total to 2534 infants whose mothers were exposed to inhaled budesonide. Your healthcare provider may check your breathing, do blood tests and eye exams during treatment with Pulmicort Flexhaler. It will not work fast enough to treat an asthma attack.
Tell your doctor if you are pregnant before using Pulmicort Flexhaler. As with other inhaled asthma medications, bronchospasm, with an immediate increase in wheezing, may occur after dosing. Table 1 : Adverse Reactions occurring at an incidence of 1 and more commonly than placebo in the pulmicort flexhaler (budesonide inhalation powder) group: pooled data from two 12-week, double-blind, placebo-controlled clinical asthma trials in patients 6 years and older Adverse Event pulmicort flexhaler (budesonide. 10 Worst Cities for Asthma Slideshow Pictures Pulmicort Flexhaler Consumer Information Get emergency medical help if you have signs of an allergic reaction : hives, rash, severe itching; chest pain, difficult breathing, feeling anxious; swelling of your face, lips, tongue, or throat.
Tell your doctor right away if you develop unusual/extreme tiredness or weight loss. Avoid contact with people who have infections that may spread to others (such as chickenpox, measles, flu ). This medication passes into breast milk. Adverse reactions, regardless of investigator causality assessment, reported in more than five patients in the budesonide group and which occurred more commonly than the placebo group in decreasing order of frequency include: respiratory infection, sinusitis, headache, oral candidiasis, pain, asthenia, dyspepsia, arthralgia, cough increased, nausea. In these trials, the patients on pulmicort flexhaler had a mean age of 28 years (range 6-80 years) and were predominantly Caucasian (59.7) and Asian (31.4). The effect on final adult height is unknown. Common side effects may include: runny or stuffy nose, sneezing; red, itchy, and watery eyes; fever, sore throat, cough; nausea, vomiting, diarrhea, stomach pain, loss of appetite; nosebleed; or headache, back pain. In a 20-week trial in adult asthmatics who previously required oral corticosteroids, the incidence of adverse reactions was evaluated with 400 mcg twice daily (N53) and 800 mcg twice daily (N53) of inhaled budesonide via a different pulmicort dry powder inhaler and compared with placebo. Inhaled corticosteroids may cause a reduction in growth rate. Before using this medication, tell your doctor or pharmacist your medical history, especially of: eye disease (such as cataracts, glaucoma high blood pressure, liver disease, thyroid problems, diabetes, stomach /intestinal problems (such as diverticulitis, ulcer bone loss ( osteoporosis current/past infections (such as tuberculosis, positive. Avoid contact with people who have recently received live vaccines (such as flu vaccine inhaled through the nose).